Trial intelligence / Profile preview

Boosted Atazanavir in HIV+ Children with Elevated Lipids

NCT00940771Phase 4Completed

Sponsor
Phoenix Children's
Start
Aug 2009
Primary completion
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Phoenix Children's. Started Aug 2009; status: completed.

02

Drugs

atazanavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00940771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00940771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call